share_log

Coherus BioSciences:Chs-114在经过大量预处理的实体瘤患者中显示出可接受的安全性且没有剂量限制毒性

Coherus BioSciences: Chs-114 Shows Acceptable Safety and No Dose-Restricted Toxicity in Highly Pretreated Solid Tumor Patients

Zhitong Finance ·  May 24 05:52
Coherus BioSciences: Chs-114 Shows Acceptable Safety and No Dose-Restricted Toxicity in Highly Pretreated Solid Tumor Patients

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment